A 53-Year-Old Man Presenting with Pancreatic Exocrine Insufficiency 7 Years After Gastric Bypass Bariatric Surgery.


Journal

The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566

Informations de publication

Date de publication:
29 Jun 2022
Historique:
entrez: 29 6 2022
pubmed: 30 6 2022
medline: 1 7 2022
Statut: epublish

Résumé

BACKGROUND Pancreatic exocrine insufficiency (PEI) is a clinical condition characterized by reduced or inappropriate pancreatic enzymes and secretions. It can have a variable clinical presentation and can affect patient quality of life. PEI can be associated with pancreatic and nonpancreatic disorders. Pancreatic insufficiency is a recognized complication of bariatric surgery, but there is limited awareness. This report is of a 53-year-old man who presented with PEI 7 years after his initial bariatric surgery. Revision surgery resulted in the resolution of chronic diarrhea and progressive weight loss. CASE REPORT A 53-year-old man who had gastric bypass surgery had developed pancreatic insufficiency 7 years after the surgery. This diagnosis was a challenge to make and therefore treat. A multi-modal approach and revision surgery helped resolve his symptoms. CONCLUSIONS Pancreatic insufficiency is a challenging complication to treat after bariatric surgery. Its management includes a multi-disciplinary approach, and such cases should be managed in dedicated bariatric units. This report has highlighted the importance of excluding PEI as a complication of bariatric surgery and its management.

Identifiants

pubmed: 35765219
pii: 936880
doi: 10.12659/AJCR.936880
pmc: PMC9252308
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e936880

Références

Gastroenterol Clin North Am. 2016 Dec;45(4):571-579
pubmed: 27837773
Obes Surg. 2015 Oct;25(10):1822-32
pubmed: 25835983
Nutrients. 2020 Oct 12;12(10):
pubmed: 33053816
Gut. 2005 Jul;54 Suppl 6:vi1-28
pubmed: 15951527
Surgery. 2014 Feb;155(2):271-9
pubmed: 24287147
Pancreatology. 2002;2(6):528-34
pubmed: 12435865
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv
pubmed: 19726018
Obes Surg. 2009 Apr;19(4):412-7
pubmed: 18704604
Obes Surg. 2011 Jan;21(1):119-24
pubmed: 20680504
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
Z Gastroenterol. 2015 Dec;53(12):1447-95
pubmed: 26666283
Scand J Gastroenterol. 2001 Oct;36(10):1092-9
pubmed: 11589385
Obes Surg. 2012 May;22(5):740-8
pubmed: 22354457
Gastroenterology. 2019 Jul;157(1):119-127.e1
pubmed: 30940524
Gastroenterol Hepatol (N Y). 2015 Aug;11(8):526-35
pubmed: 27118949
Obes Surg. 2016 Dec;26(12):2974-2980
pubmed: 27216731
Obes Surg. 2005 May;15(5):648-54
pubmed: 15946455
Surg Obes Relat Dis. 2016 May;12(4):790-794
pubmed: 26965152
Ann Clin Biochem. 2016 Jan;53(Pt 1):21-31
pubmed: 25947642
Pancreas. 2016 Sep;45(8):1104-10
pubmed: 26918874
Pancreatology. 2018 Jan;18(1):39-45
pubmed: 29221631
Nutrients. 2017 Nov 13;9(11):
pubmed: 29137169
United European Gastroenterol J. 2017 Mar;5(2):153-199
pubmed: 28344786
Fukushima J Med Sci. 2017 Apr 28;63(1):1-7
pubmed: 28450665
Int J Obes (Lond). 2013 Nov;37(11):1452-9
pubmed: 23419600
Obes Surg. 2013 Oct;23(10):1616-23
pubmed: 24022341
Aliment Pharmacol Ther. 1988 Dec;2(6):493-500
pubmed: 2979271

Auteurs

Mohit Bhatia (M)

Department of General & Laparoscopic Surgery, Princess Royal University Hospital, King's College, Orpington, London, United Kingdom.

Bindhiya Thomas (B)

Department of General & Laparoscopic Surgery, Princess Royal University Hospital, King's College London, Orpington, London, United Kingdom.

Sukhdev Chatu (S)

Department of General & Laparoscopic Surgery, Princess Royal University Hospital, King's College London, Orpington, London, United Kingdom.

Shamsi El-Hasani (S)

Department of General & Laparoscopic Surgery, Princess Royal University Hospital, King's College London, Orpington, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH